Back
Blueprint Medicines Stock Price Chart
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
37
BPMC
Blueprint Medicines
Last Price:
94.81
Seasonality Move:
-0.18%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Blueprint Medicines Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 94.66 | Buy |
| 20-day SMA: | 92.39 | Buy |
| 50-day SMA: | 90.02 | Buy |
| 200-day SMA: | 95.85 | Sell |
| 8-day EMA: | 94.12 | Buy |
| 20-day EMA: | 93.09 | Buy |
| 50-day EMA: | 92.24 | Buy |
| 200-day EMA: | 91.11 | Buy |
Blueprint Medicines Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.39 | Buy |
| Relative Strength Index (14 RSI): | 54.43 | Buy |
| Chaikin Money Flow: | 456578 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (85.11 - 97.25) | Buy |
| Bollinger Bands (100): | (85.77 - 106.49) | Sell |
Blueprint Medicines Technical Analysis
| Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Blueprint Medicines Stock
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 94.81 while BPMC 8-day simple moving average is 94.66, which is a Buy signal.
- The stock price of BPMC is 94.81 while Blueprint Medicines 20-day SMA is 92.39, which makes it a Buy.
- Blueprint Medicines 50-day simple moving average is 90.02 while BPMC share price is 94.81, making it a Buy technically.
- BPMC stock price is 94.81 and Blueprint Medicines 200-day simple moving average is 95.85, creating a Sell signal.
BPMC Technical Analysis vs Fundamental Analysis
Sell
37
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines a Buy or a Sell?
-
Blueprint Medicines stock is rated a Sell
The current Blueprint Medicines [BPMC] share price is $94.81. The Score for BPMC is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Blueprint Medicines Stock Info
Market Cap:
6.02B
Price in USD:
94.81
Share Volume:
555.43K
Blueprint Medicines 52-Week Range
52-Week High:
121.90
52-Week Low:
63.50
Sell
37
Blueprint Medicines (BPMC)
is a Sell
Blueprint Medicines Share Price Forecast
-
What is the Blueprint Medicines stock price today?
The Blueprint Medicines stock price is 94.81 USD today. -
Will BPMC stock go up or go down?
Blueprint Medicines> share price is forecast to RISE/FALL based on technical indicators -
Is Blueprint Medicines overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Blueprint Medicines is overvalued.
Is Blueprint Medicines Stock a Buy?
- Blueprint Medicines share price is 94.81 while BPMC 8-day exponential moving average is 94.12, which is a Buy signal.
- The stock price of BPMC is 94.81 while Blueprint Medicines 20-day EMA is 93.09, which makes it a Buy.
- Blueprint Medicines 50-day exponential moving average is 92.24 while BPMC share price is 94.81, making it a Buy technically.
- BPMC stock price is 94.81 and Blueprint Medicines 200-day simple moving average is 91.11, creating a Buy signal.
Fundamental Analysis of Blueprint Medicines
Is Blueprint Medicines a good investment?
- Analysts estimate an earnings increase this quarter of $0.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.18 per share, and an increase next year of $0.64 per share.
Technical Analysis of Blueprint Medicines
Should I short Blueprint Medicines stock?
- BPMC Moving Average Covergence Divergence (MACD) indicator is 1.39, suggesting Blueprint Medicines is a Buy
- Blueprint Medicines Relative Strength Index (RSI) is 54.43, which suggest Blueprint Medicines is overbought
- The Bollinger Bands (25) for Blueprint Medicines is (85.11 - 97.25), which suggest Blueprint Medicines is a Sell
- The Bollinger Bands (100) for Blueprint Medicines is (85.77 - 106.49), which suggest Blueprint Medicines is a Sell
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.